View of a Russian research institute <br>[Image source=Yonhap News]

View of a Russian research institute
[Image source=Yonhap News]

View original image

[Asia Economy Intern Reporter Hee-eun Park] It has been reported that a Russian national research institute is developing a novel coronavirus (COVID-19) preventive vaccine administered as drops into the nose.


According to TASS news agency on the 30th (local time), Rinat Maksutov, director of the State Research Center of Virology and Biotechnology 'Vector' located in Novosibirsk, Siberia, stated that the institute is developing a COVID-19 vaccine.


'Vector' announced that it is currently conducting preclinical trials to verify the efficacy and safety of this vaccine.


They also reported that no abnormal reactions such as fever were observed in animals.


Director Maksutov explained that the vaccine being developed by the institute uses a method of administering drops into the nasal cavity rather than the traditional intramuscular injection.


Earlier, Deputy Prime Minister Tatyana Golikova announced that 47 types of COVID-19 vaccines are being developed at 14 institutions within Russia.



Meanwhile, Melita Vujnovic, representative of the World Health Organization (WHO) Moscow office, stated, "Russia has notified WHO of eight types of vaccines under development."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing